Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study

[21] Klein R(2008)Factors that influence the patient uptake of diabetic retinopathy screening Ir J Med Sci 177 303-585

[22] Echouffo-Tcheugui JB(2013)A simple risk stratification for time to development of sight-threatening diabetic retinopathy Diabetes Care 36 580-87

[23] Ali MK(2020)Risk factors for mortality among COVID-19 patients Diabetes Res Clin Pract 166 108293-1982

[24] Roglic G(2004)Retinopathy in diabetes Diabetes Care 27 S84-1732

[25] Hayward RA(2014)Glycemic control and excess mortality in type 1 diabetes N Engl J Med 371 1972-136

[26] Narayan KM(2015)Excess mortality among persons with type 2 diabetes N Engl J Med 373 1720-999

[27] Taylor-Phillips S(2015)Review of 103 Swedish Healthcare Quality Registries J Intern Med 277 94-2532

[28] Mistry H(2016)Divergent perceptions of barriers to diabetic retinopathy screening among patients and care providers, Los Angeles, California, 2014–2015 Prev Chronic Dis 13 E140-2182

[29] Leslie R(2017)Factors determining uptake of diabetic retinopathy screening in Oxfordshire Diabet Med 34 993-undefined

[30] Rosenberg JB(2011)Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy Diabetologia 54 2525-undefined

[21] Klein R(2008)Factors that influence the patient uptake of diabetic retinopathy screening Ir J Med Sci 177 303-585

[22] Echouffo-Tcheugui JB(2013)A simple risk stratification for time to development of sight-threatening diabetic retinopathy Diabetes Care 36 580-87

[23] Ali MK(2020)Risk factors for mortality among COVID-19 patients Diabetes Res Clin Pract 166 108293-1982

[24] Roglic G(2004)Retinopathy in diabetes Diabetes Care 27 S84-1732

[25] Hayward RA(2014)Glycemic control and excess mortality in type 1 diabetes N Engl J Med 371 1972-136

[26] Narayan KM(2015)Excess mortality among persons with type 2 diabetes N Engl J Med 373 1720-999

[27] Taylor-Phillips S(2015)Review of 103 Swedish Healthcare Quality Registries J Intern Med 277 94-2532

[28] Mistry H(2016)Divergent perceptions of barriers to diabetic retinopathy screening among patients and care providers, Los Angeles, California, 2014–2015 Prev Chronic Dis 13 E140-2182

[29] Leslie R(2017)Factors determining uptake of diabetic retinopathy screening in Oxfordshire Diabet Med 34 993-undefined

[30] Rosenberg JB(2011)Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy Diabetologia 54 2525-undefined